NFL Biosciences
Develops botanical drug candidates to treat smoking and alcohol addictions.
ALNFL | PA
Overview
Corporate Details
- ISIN(s):
- FR0014003XO1 (+1 more)
- LEI:
- 9695006VJWNTN4UNHA27
- Country:
- France
- Address:
- 199 RUE HELENE BOUCHER, 34170 CASTELNAU-LE-LEZ
- Website:
- https://www.nflbiosciences.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
NFL Biosciences is a biopharmaceutical company that develops botanical drug candidates for the treatment of addictions. The company's lead asset is NFL-101, an innovative drug candidate for smoking cessation derived from a nicotine-free protein extract of tobacco leaves. Its pipeline also includes NFL-301, a candidate aimed at reducing excessive alcohol consumption. NFL Biosciences operates with an outsourced research model, focusing on advancing its products through preclinical and clinical studies. The company's primary business strategy is to license its developed drug candidates to larger pharmaceutical companies for final commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-09-27 17:45 |
NFL BIOSCIENCES : RAPPORT FINANCIER SEMESTRIEL au 30 juin 2024
|
French | 2.6 MB | ||
| 2024-09-27 17:45 |
NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
|
English | 198.7 KB | ||
| 2024-09-27 17:45 |
NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS DU 1er SEMESTRE 2024
|
French | 214.8 KB | ||
| 2024-09-09 17:45 |
NFL BIOSCIENCES : AGENDA DE PARTICIPATION ÉVÉNEMENTS PHARMA ET INVESTISSEURS IN…
|
French | 221.2 KB | ||
| 2024-09-09 17:45 |
NFL BIOSCIENCES: PARTICIPATION CALENDAR PHARMA EVENTS AND INSTITUTIONAL INVESTO…
|
English | 213.6 KB | ||
| 2024-07-15 08:00 |
NFL BIOSCIENCES : RÉSULTATS DE L’ÉTUDE CESTO II
|
French | 1.0 MB | ||
| 2024-07-15 08:00 |
NFL BIOSCIENCES: CESTO II STUDY RESULTS
|
English | 958.0 KB | ||
| 2024-07-11 17:45 |
NFL BIOSCIENCES : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ DU 1er SEMESTRE 2024
|
French | 1.4 MB | ||
| 2024-06-17 11:00 |
NFL BIOSCIENCES : publication scientifique de l'étude sur le mécanisme d'action…
|
French | 465.7 KB | ||
| 2024-06-17 11:00 |
NFL BIOSCIENCES: Scientific publication of the study on the mechanism of action…
|
English | 403.3 KB | ||
| 2024-05-31 17:45 |
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
|
English | 389.2 KB | ||
| 2024-05-31 17:45 |
NFL BIOSCIENCES : COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 30 MAI 2024
|
French | 584.1 KB | ||
| 2024-05-29 08:00 |
NFL BIOSCIENCES : présentation des résultats de l'étude menée avec le CEA, au c…
|
French | 456.2 KB | ||
| 2024-05-29 08:00 |
NFL BIOSCIENCES : Presentation of the study results conducted with the CEA at t…
|
English | 402.8 KB | ||
| 2024-05-21 08:00 |
NFL BIOSCIENCES : RETOUR POSITIF DE LA FDA SUR LA DEMANDE DE PRE-IND POUR NFL-3…
|
French | 501.9 KB |
Automate Your Workflow. Get a real-time feed of all NFL Biosciences filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NFL Biosciences
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NFL Biosciences via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
